Opinion
Index No. 190145/2021 Motion Seq. No. 017
08-14-2023
Unpublished Opinion
MOTION DATE 06/09/2023
PRESENT: HON. ADAM SILVERA Justice
DECISION + ORDER ON MOTION
ADAM SILVERA J.S.C.
The following e-filed documents, listed by NYSCEF document number (Motion 017) 614, 615, 616, 617, 618, 619, 620, 621,622, 623, 627. 628, 644, 647, 648, 649, 656, 657 were read on this motion to/for DISCOVERY.
Upon the foregoing documents, it is ordered that defendant Mercedes-Benz USA, LLC's ("MBUSA") motion seeking (1) an out-of-state subpoena to obtain the tissue block taken during plaintiff Almando Rodney's ("Mr. Rodney") pleurectomy and (2) an order permitting MBUSA's expert, Timothy D. Oury, MD, PhD, ("Dr. Oury") to perform digestion studies on such tissue block, is decided in accordance with the decision below.
Here, defendant MBUSA contends that 0.2-0.3 grams of Mr. Rodney's 1.4-gram tissue if sample, currently preserved at one of his treating hospitals in Florida, Should be made available to Dr, Oury for purposes of further testing, upon which to base his opinion on the cause of Mr. Rodney's mesothelioma. See Affirmation in Support of MBUSA's Motion, p. 7. Plaintiff opposes the instant order to show cause, highlighting that the Note of Issue has already been filed in this action, and relying on the expert opinion of Mr. Rodney's treating oncologist, Evan f Alley, MD, PhD.
Primarily, the Court notes that moving defendant's request herein does not constitute "unusual or unanticipated circumstances" justifying post-Note of Issue discovery as required by the Case Management Order dated June 20, 2017 ("CMO"). The CMO permits post-NOI discovery pursuant to the Uniform Rules for the New York State Trial Courts §202.21(d). See CMO, IX.O. The Uniform Rules state that "[w]here unusual or unanticipated circumstances develop subsequent to the filing of a note of issue which require additional pretrial proceedings to prevent substantial prejudice, the court, upon motion supported by affidavit, may grant permission to conduct such necessary proceedings". 22 NYCRR §202.21 (d). Here, the lack of such circumstances is particularly egregious given that Mr. Rodney is a living mesothelioma plaintiff, and that defendant MBUSA has been "aware of [Mr. Rodney's] pleurectomy as early as August of 2021" and received "pathology materials. ..18 months ago." Plaintiffs Affirmation in Opposition to Mercedes Benz, U.S.A., Order to Show Cause, p. 3. Given the apparent necessity of such testing to defendant MBUSA's defense, this request should have been prioritized and i made at an earlier stage.
Additionally, the Court finds that defendant MBUSA's interest in the tissue sample does not outweigh Mr. Rodney's health interests herein. As defendant has nested, the Court of Appeals held in Koump v Smith that when a plaintiffs physical condition is placed "in controversy," physical tests may be justified in certain cases. See Koump v Smith, 25 N.Y.2d 287 (1969). However, defendant misconstrues the caselaw and fails to meet the appropriate standard for such tests. The facts in the instant case are vastly different from all of the caselaw relied upon by defendant. One such case, Pettinato v EQR-Rivertower, LLC, emphasized the need to "balance the desire for the plaintiff to be examined safely...against the need for the defendant to determine facts in the interest of truth." Pettinato, 213 A.D.3d 46, 51 (1st Dep't 2023) (internal citations omitted). The court further stated that "a showing of the medical importance and safety of the particular procedure is required, as well as an explanation of the relevance and the need for the information that a procedure will yield." Id.
Dr. Oury's affidavit contains no such definitive showings. He indicates clear uncertainty as to the amount of plaintiffs tissue actually needed for digestion testing. See Affidavit in Support, supra, Affidavit of Tim. D. Oury, MD, PhD, p. 2-3 ("I will need to see the actual tissue under the microscope to make a firm conclusion about the amount of tissue needed for digestion".). Dr. Oury cites no supportive studies or any other evidence to indicate the accuracy of such testing, its common use, or any other relevant factors. It is also clear that Dr. Oury has reviewed the slides and pathology report from Mr. Rodney's surgery, and he offers no explanation as to why these, and the other records already made available to him, are insufficient upon which to base his opinion. Mr. Rodney's testimony, medical records, and other discovery previously exchanged suffices MBUSA to formulate their defense as to the extent of Mr. Rodney's exposure to their products and the likelihood of asbestos exposure therein.
Further, both defendant MBUSA and Dr. Oury make the unsupported assertion that I testing a portion of plaintiffs tissue block would not be invasive or harmful. Mr. Rodney's treating physician clearly states otherwise. See Affirmation in Opposition, supra. Exh. 2, Affidavit of Evan Alley, MD, Phd, p. 1 -2. It is currently unknown how much tissue Mr. Rodney may need to provide for purposes of further treatment, including clinical trials. Dr. Alley opines that it would be invasive and harmful to undergo surgery to replace the tissue again, should Dr. Oury's unspecified, extracted amount prove to exclude Mr. Rodney from such trials/treatments. See id. at p. 2. Unlike a massive surgical undertaking, such as Mr. Rodney's pleurectomy herein, the court in Pettinato also highlighted that a pelvic examination is a "routine practice" that a patient can undergo again. See Pettinato, supra, at p. 54.
Defendant's other cited examples are similarly unconvincing arid wholly inapplicable here. Defendant MBUSA fails to proffer any caselaw even remotely similar to the extenuating circumstances at issue herein-a living plaintiff with a type of terminal cancer who has undergone a massively invasive surgery to obtain a finite biological sample that may be necessary to his further treatment. See Castrillon v City of New York, 91 A.D.2d 986 (2d Dep't 1983) (discussing X-rays of an injury that were taken several years prior to the request and could be designated by movants as easily as within a ten-day period, much unlike a terminal illness and surgery); Matter of Oliver v England, 48 Misc.2d 335, 337 (Family Ct. Monroe Co. 1965) (entirely irrelevant; concerning the admissibility of a blood test that was voluntarily submitted to and not court-ordered); Adlerstein v South Nassau Communities Hospital, 109 Misc.2d 158, 164 (Sup. Ct. Nassau Co. 1981) (semen test was concrete and firmly decisive as to determining sterility "and painless"); Thomas v John T. Mather Memorial Hospital, 162 A.D.2d 521, 522 (2d Dep't 1990) (highlighted repeatability of CAT scans, plaintiff had already undergone multiple, "conventionally accepted method of determining the nature and extent'" of injury at issue); Jenny Shulman v Brenntag North America, 2019 NY Slip Op 30757(U), at *3 (the parties had already attempted to obtain the pathology sample prior to the Note of Issue but were prevented from doing so by procedural delays at the hospitals).
Accordingly, it is
ORDERED that defendant MBUSA's motion is denied in its entirety; and it is further
ORDERED that within 30 days of entry plaintiff shall serve all parties with a copy of this Decision/Order with notice of entry.
This constitutes the Decision/Order of the Court.